VTE Risks and JAK inhibition
Mar 13, 2023
Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
Use this resource to keep track of your clinical trials and key information needed when communicating with patients about a drug study.
Comparison of COVID-19 deaths in the first 3 mos vs. over 30 mos since onset. USA leads the way.
An overview of how to use serologic testing - ANA, RF, CCP, ESR, CRP